Fifteen years of clinical science.
Now in your hands.
This is the page where we show our work.
SwissNovaGene
SwissNovaGene is a Swiss biotechnology company founded to develop and validate active micronutrition formulas through rigorous clinical research. Our work sits at the intersection of nutrition science, nutrigenomics, and clinical pharmacology.
We do not formulate based on trends. We formulate based on biological mechanisms, then we run human clinical trials to prove the result. Our formulas have been studied and validated in clinical studies — the same standard used for pharmaceutical research.
Over 15 years, we have built a portfolio of patent-pending formulas, each addressing a specific physiological function: sleep, immunity, stress regulation, energetic metabolism, and detoxification.
Combinatorial micronutrition
Combinatorial micronutrition is our core technology. It is the science of assembling microdosed natural ingredients — trace elements, vitamins, minerals, plant extracts, oils — in precise synergistic combinations that produce measurable clinical outcomes.
The premise is simple: biology works in synergies, not in isolated ingredients. A single nutrient, even at a high dose, rarely produces the effect that a precise combination of micronutrients can produce together. The interaction is the medicine.
This is why our formulas use small doses of many ingredients rather than large doses of one. It is also why they are difficult to copy: the effect lives in the combination, not the components.
Clinical evidence summary
SLEEP — BIOPTIL®
Double-blind randomized clinical trial. 160 participants. 42% reduction in sleep disorder scores within 4 weeks (vs. 16% placebo). EEG validated. Published clinical methodology.
STRESS — SERENIUM®
Double-blind randomized clinical trial. 158 participants. Hamilton Stress Scale validated. 65.4% of participants fully resolved stress symptoms within 8 weeks. 42.9% reduction in overall stress intensity (vs. 19.7% placebo).
DETOX — DETOXIN®
4 Phase 2 clinical studies. 88% of patients normalized total cholesterol within 2 months. 92% of pre-diabetic patients normalized blood glucose. 92% normalized uric acid levels. 80% recovery from post-anaesthesia symptoms within 8 days.
IMMUNITY — VITALIM®
Multiple controlled clinical studies. 82.5% of participants avoided winter infections during supplementation. 50% reduction in infection frequency in at-risk populations. Collaboration with Institut Pasteur.
METABOLISM — LIPOGENOL®
Clinical studies on lipid and energetic metabolism. LDL cholesterol reduced by 10%; triglycerides reduced by 20%. Mechanism: restoration of energetic metabolism at the muscular level. Strong impact on muscle quality and weight control.
Regulatory & quality
All Move products are classified as food supplements under Swiss, French, and EU regulations. They contain authorized ingredients in compliant doses, manufactured in Switzerland under Swiss food safety standards.
PATENT STATUS
Patent-pending formulas. The combination and manufacturing process are protected.
REGULATORY CLASS
Food supplement classification. Swiss, French, and EU compliant. No prescription required.
MANUFACTURING
Made in Switzerland. Produced under GMP standards. Third-party tested for contaminants and label accuracy.
Working in clinical or research settings?
Detailed clinical study data, full ingredient profiles, and regulatory documentation are available on request to qualified researchers, clinicians, and institutional buyers. We do not publish full clinical data publicly to protect IP, but we share it readily under NDA.